News & Events category:
Manchester Royal Eye Hospital

Manchester University NHS Foundation Trust's (MFT) innovative approach to enhanced patient care.

A 79-year-old woman is the first global participant to a research study that could help some of the millions of people worldwide living with glaucoma – a leading cause of irreversible blindness.

MFT, Research and Innovation colleagues mark 75 years of the National Health Service (NHS).

The first UK participant has been recruited to a research study that could potentially help millions of people living with a condition that can lead to irreversible blindness.

A world-first scientific study has shown that whole genome sequencing can uncover new diagnoses for people across the broadest range of rare diseases investigated to date.

Ground-breaking research taking place at Manchester Royal Eye Hospital is trialling a new investigational gene therapy designed to halt the progression of dry age-related macular Degeneration (AMD).

Staff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research